KPA Launches Investigations on Unfair Business Transactions by Manufacturers

Published: 2004-12-28 07:00:00

Updated: 2004-12-28 07:00:00

The Korea Pharmaceutical Association (KPA) announced that it plans to enforce strict measures on the pharmaceutical manufacturers if they are found to practice unfair business transactions with the retail pharmacies.

The KPA has initiated an investigational review starting December 24th, by co...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK